A prospective therapy alternative for neurological diseases, such as Alzheimer’s, Parkinson’s, and Huntington’s disease as well as for the prevention and the advancement of neuroinflammaging, is now thought to include SIRT1 and the other sirtuins [53]. The gene discussed is SIRT1; the disease is Parkinson disease.